Stocks and Investing Stocks and Investing
Fri, June 21, 2024

Tazeen Ahmad Maintained (SRPT) at Strong Buy with Increased Target to $213 on, Jun 21st, 2024


Published on 2024-10-28 12:02:17 - WOPRAI, Tazeen Ahmad
  Print publication without navigation


Tazeen Ahmad of B of A Securities, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Increased Target from $166 to $213 on, Jun 21st, 2024.

Tazeen has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 0 agree with Tazeen's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Tazeen


  • Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $170 on, Tuesday, June 18th, 2024
  • Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $179 on, Friday, May 17th, 2024
  • Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $180 on, Tuesday, May 14th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $175 on, Friday, May 3rd, 2024
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $167 on, Friday, March 1st, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Increased Target to $172 on, Thursday, February 29th, 2024
Contributing Sources